Project description
Novel platform at the service of drug discovery for brain disease
Most techniques for functional imaging either interfere with cellular viability and physiology or provide poor resolution. To address these limitations, scientists of the EU-funded Ima-Go project have investigated the commercial feasibility of a 96-well platform that is label-free, non-invasive and can be used with live human cells for high-quality readouts. The platform uses electrodes to track neuronal activity, offering a novel solution for pharmaceutical companies interested in drug development for brain diseases. The Ima-Go project will further scale this technology to a high-throughput platform required in the drug discovery pipeline and introduce novel biological assays that cannot be performed by current competing technologies.
Fields of science
- natural sciencesbiological sciencesneurobiology
- medical and health sciencesbasic medicinepharmacology and pharmacydrug discovery
- medical and health sciencesmedical biotechnologycells technologiesstem cells
- medical and health sciencesbasic medicineneurologydementia
- medical and health sciencesbasic medicinephysiology
Programme(s)
Funding Scheme
SME-1 - SME instrument phase 1
Coordinator
8047 Zurich
Switzerland
See on map